Merck Bolsters Januvia Access With Outcomes-Based Discounts To CIGNA

Merck will provide CIGNA with price discounts on Januvia and Janumet that are tied to member outcomes - lower blood sugar and medication adherence - in a novel contract arrangement announced by CIGNA April 23